CK19 belonging to the family of keratins plays a key role in tumor malignancy through overexpression and can be used as a potential biomarker to predict adverse prognosis after surgery and adjuvant therapy in HBV-related HCC patients [89]. Here, KRT19 is linked to neoplasm.